At A-Rich, a global healthcare powerhouse, we’ve been dedicated to enriching the health and well-being of individuals worldwide since our inception in 1989.
Embracing a pioneering stance in essential plasma-derived medicines and transfusion medicine, we strive to develop, produce, and provide cutting-edge healthcare services and solutions.
With a profound understanding of various chronic, rare, and life-threatening diseases, we channel our ever-growing knowledge into innovative approaches for both plasma and other biopharmaceuticals, ultimately enhancing the quality of life.
A-Rich is committed to addressing conditions across diverse therapeutic areas, including neurology, immunology, hepatology, intensive care, pulmonology, hematology, and infectious diseases.
A-Rich Plasma Products (R&D) pioneers transformative innovation in diverse plasma products, including Albumin, clotting factors, and immunoglobulins. Our multidisciplinary team ensures excellence from meticulous objective setting to full-scale production, emphasizing quality, scalability, and regulatory compliance. Committed to ongoing research, collaborations, and intellectual property protection, A-Rich leads in critical care, immunotherapy, and hematology.
As industry pioneers, we boast an extensive collaboration network with donation centers nationwide, solidifying our position as a leader in the plasma sector.
© 2024 arichlab All rights reserved.